people
< President Jo-Won Lee >
Chair professor Jo-Won Lee from Hanyang University was appointed as the sixth president of the National Nano Fab Center (NNFC). President Lee will serve his term for three years from September 16.
The NNFC is an affiliated institution of KAIST, established in 2002 to foster qualified manpower in the field of nanotechnology (NT) in Korea. The NNFC features cutting-edge NT-related research equipment and fabrication services, and provides students and researchers quality education and training. The NNFC seeks to become a world-leading institute by performing extensive business operations including the commercialization of NT research results and conducting various multidisciplinary projects.
President Lee received his BS degree from Hanyang University and his MS and PhD degrees in metals science from the Pennsylvania State University. He taught nano-conversion science at his alma mater, Hanyang University, while serving as the director of the National Program for Tera-level Nanodevices. President Lee also guided the governmental planning committee for the 10-year Korea Nanotechnology Initiative as secretary general.
President Lee said, “The NNFC has been striving to develop Korea as the world’s strongest nation in nanotechnology thus far. All of the members of the NNFC will continue giving our best effort for the improvement of our nation’s nanotechnology.”
(END)
-
research KAIST & CMU Unveils Amuse, a Songwriting AI-Collaborator to Help Create Music
Wouldn't it be great if music creators had someone to brainstorm with, help them when they're stuck, and explore different musical directions together? Researchers of KAIST and Carnegie Mellon University (CMU) have developed AI technology similar to a fellow songwriter who helps create music. KAIST (President Kwang-Hyung Lee) has developed an AI-based music creation support system, Amuse, by a research team led by Professor Sung-Ju Lee of the School of Electrical Engineering in collaboration
2025-05-07 -
research Editing Parkinson's Disease – KAIST Makes World's First Discovery of an Inflammatory RNA Editing Enzyme through Co-work with UCL Researchers
< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02 -
research KAIST sends out Music and Bio-Signs of Professor Kwon Ji-yong, a.k.a. G-Dragon, into Space to Pulsate through Universe and Resonate among Stars
KAIST (President Kwang-Hyung Lee) announced on the 10th of April that it successfully promoted the world’s first ‘Space Sound Source Transmission Project’ based on media art at the KAIST Space Research Institute on April 9th through collaboration between Professor Jinjoon Lee of the Graduate School of Culture Technology, a world-renowned media artist, and the global K-Pop artist, G-Dragon. This project was proposed as part of the ‘AI Entertech Research Center’ be
2025-04-10 -
event KAIST, Galaxy Corporation Hold Signboard Ceremony for ‘AI Entertech Research Center’
KAIST (President Kwang-Hyung Lee) announced on the 9th that it will hold a signboard ceremony for the establishment of the ‘AI Entertech Research Center’ with the artificial intelligence entertech company, Galaxy Corporation (CEO Yong-ho Choi) at the main campus of KAIST. < (Galaxy Corporation, from center to the left) CEO Yongho Choi, Director Hyunjung Kim and related persons / (KAIST, from center to the right) Professor SeungSeob Lee of the Department of Mechanical Engineer
2025-04-09 -
research KAIST Identifies Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening
2025-04-08